Cash on Hand for Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's latest reported cash and short-term investments is $7.27B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingCash on HandSwitch metric
Latest period
$7.27B
YoY change
+112.3%
5Y CAGR
+14.6%
Peak year (2017)
$8.03B
Latest annual
$7.27B
Cash on Hand history chart for Eli Lilly (LLY) from 1985 to 2025
Cash on Hand history table for Eli Lilly (LLY) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $7.27B | +112.3% | ||
| 2024 | $3.42B | +16.9% | ||
| 2023 | $2.93B | +32.4% | ||
| 2022 | $2.21B | -43.4% | ||
| 2021 | $3.91B | +6.2% | ||
| 2020 | $3.68B | +51.0% | ||
| 2019 | $2.44B | -67.1% | ||
| 2018 | $7.41B | -7.8% | ||
| 2017 | $8.03B | +33.0% | ||
| 2016 | $6.04B | +35.6% | ||
| 2015 | $4.45B | -7.8% | ||
| 2014 | $4.83B | -10.6% | ||
| 2013 | $5.40B | -5.0% | ||
| 2012 | $5.68B | -17.6% | ||
| 2011 | $6.90B | +2.5% | ||
| 2010 | $6.73B | +49.6% | ||
| 2009 | $4.50B | -24.1% | ||
| 2008 | $5.93B | +22.7% | ||
| 2007 | $4.83B | +24.2% | ||
| 2006 | $3.89B | -22.8% | ||
| 2005 | $5.04B | -32.5% | ||
| 2004 | $7.46B | +101.0% | ||
| 2003 | $3.71B | +1.6% | ||
| 2002 | $3.65B | -2.0% | ||
| 2001 | $3.73B | -19.2% | ||
| 2000 | $4.62B | +20.4% | ||
| 1999 | $3.84B | +156.5% | ||
| 1998 | $1.50B | -23.2% | ||
| 1997 | $1.95B | +139.3% | ||
| 1996 | $813.70M | -18.6% | ||
| 1995 | $999.50M | +86.2% | ||
| 1994 | $536.90M | -0.5% | ||
| 1993 | $539.60M | +24.8% | ||
| 1992 | $432.40M | -9.8% | ||
| 1991 | $479.20M | +36.8% | ||
| 1990 | $350.20M | +8.4% | ||
| 1989 | $323.00M | -57.6% | ||
| 1988 | $761.50M | -26.1% | ||
| 1987 | $1.03B | +112.1% | ||
| 1986 | $486.00M | +19.7% | ||
| 1985 | $406.10M | — |
Cash on Hand values are taken from Eli Lilly's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Eli Lilly (LLY) cash and short-term investments totalled $7.27B – surged 112.3% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Eli Lilly cash and short-term investments compounded at +14.6% per year, sustaining 3 straight years of year-over-year growth.
Between 2017 and 2025, Eli Lilly cash and short-term investments declined 9.5%, falling from $8.03B to $7.27B.
The highest annual cash and short-term investments of $8.03B was reported in 2017. The lowest in the available history was $323.00M in 1989.
Within Healthcare, Eli Lilly (LLY) ranks 7th among 8 peers we track. The peer median for cash and short-term investments is $12.34B.
Eli Lilly Cash on Hand by Year
Eli Lilly Cash on Hand 2025: $7.27B
Eli Lilly cash and short-term investments in 2025 was $7.27B, surged 112.3% from 2024.
Eli Lilly Cash on Hand 2024: $3.42B
Eli Lilly cash and short-term investments in 2024 was $3.42B, grew 16.9% from 2023.
Eli Lilly Cash on Hand 2023: $2.93B
Eli Lilly cash and short-term investments in 2023 was $2.93B, surged 32.4% from 2022.
Eli Lilly Cash on Hand 2022: $2.21B
Eli Lilly cash and short-term investments in 2022 was $2.21B, plunged 43.4% below 2021.
Eli Lilly Cash on Hand 2021: $3.91B
Eli Lilly cash and short-term investments in 2021 was $3.91B.
See more financial history for Eli Lilly (LLY).
Sector peers — Cash on Hand
Companies in the same sector as Eli Lilly, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $10.11B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Eli Lilly's cash and short-term investments?
- Latest reported cash and short-term investments for Eli Lilly (LLY) is $7.27B (period ending December 31, 2025).
How has Eli Lilly cash and short-term investments changed year-over-year?
- Eli Lilly (LLY) cash and short-term investments changed +112.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly cash and short-term investments?
- Eli Lilly (LLY) cash and short-term investments compound annual growth rate is +14.6% over the most recent 5 years available.
When did Eli Lilly cash and short-term investments hit its highest annual value?
- Eli Lilly cash and short-term investments reached its highest annual value of $8.03B in 2017.
What was Eli Lilly cash and short-term investments in 2024?
- Eli Lilly (LLY) cash and short-term investments in 2024 was $3.42B.
What was Eli Lilly cash and short-term investments in 2025?
- Eli Lilly (LLY) cash and short-term investments in 2025 was $7.27B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.